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esponsibility of Xi’Abstract In the present study, we studied the effect of Genistein against the hepatotoxicity induced by
N-nitrosodiethylamine (NDEA). NDEA is present in almost all kinds of food stuff and has been reported
to be a hepatocarcinogen. The male rats were exposed to NDEA (0.1 mg/mL) dissolved in drinking water
separately and along with 25, 50, 100 mg/mL of Genistein for 21 days. The activities of serum glutamic
oxaloacetic transaminase (SGOT), serum glutamic pyruvic transaminase (SGPT), alkaline phosphatase
(ALP) and lactate dehydrogenase (LDH) were measured in blood serum. Lipid peroxidation, protein
carbonyl content, micronucleus frequency and DNA damage (Comet assay) were performed on rat
hepatocytes. The results of the study reveal that the treatment of NDEA along with Genistein showed a
signiﬁcant dose-dependent decrease in the levels of blood serum enzymes i.e., SGOT, SGPT, ALP and
LDH (Po0.05). The HE staining of histological sections of the liver also revealed a protective effect of
Genistein. A signiﬁcant dose-dependent reduction in the lipid peroxidation and protein carbonyl content
was observed in rats exposed to NDEA (0.1 mg/mL) along with Genistein (Po0.05). The results obtained
for the comet assay in rat hepatocytes showed a signiﬁcant dose-dependent decrease in the mean tail
length (Po0.05). Thus the present study supports the hepatoprotective role of Genistein.
& 2014 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Genistein is an isoﬂavone and acts as a both phytoestrogen and
antioxidant [1]. It inhibits the growth of cancerous cells by bindingsity. Production and hosting by Elsev
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2700920x3430.
rediffmail.com
an Jiaotong University.itself with the receptor in place of estrogen [2,3]. It has also been
reported to be an antihelmintic [4]. It shows protective effects
against various types of cancers [5–11]. An epidemiological study
showed that the consumption of isoﬂavones is associated with an
increased risk for hepatocellular carcinoma (HCC) in women [12].
It inhibits the bone resorption in rats [13]. It does not show
teratogenic potential in vivo even at a very high dose of 1000 mg/
kg/day by oral gavage in the embryo–fetal toxicity [14]. It has
been reported to be non-mutagenic in the Salmonella typhimuriumier B.V. All rights reserved.
F. Ali et al.52assay and non-clastogenic in the mouse and rat micronucleus test
[15]. N-nitrosocompounds (NOCs) are present in a variety of food
stuff and are well-known carcinogens [16]. One of the NOCs such
as N-nitrosodiethylamine (NDEA) has been suggested to cause
oxidative stress and cellular injury by generating free radicals [17–
19]. NDEA has been reported to generate electrophilic and reactive
oxygen species by activation of cytochrome P450 in the liver [20].
This leads to liver cytotoxicity, carcinogenicity and mutagenicity
[21]. The high intake of natural products has been reported to be
associated with a decrease in the risk of cancer and toxicity in
various epidemiological and animal studies [22]. In the present
study, the effect of Genistein was studied against NDEA-induced
hepatotoxicity in Swiss albino rats.2. Experimental
2.1. Chemicals and reagents
N-nitrosodiethylamine and Genistein were procured from Sigma
Chemicals Co. (USA). Agarose (normal and low melting), Triton
X, ethidium bromide, dimethyl sulfoxide, Tris, EDTA and all
other chemicals were purchased from SISCO Research Labora-
tories, India. May Grunwald’s stain and Giemsa stain were
procured from Merck Ltd. (India).2.2. Animals and treatment
Male rats (Wistar strain), weighing 100–120 g, were used in the
study. The animals were divided into nine groups (5 rats/group). The
ﬁrst group was allowed to feed on N-nitrosodiethylamine (NDEA)
dissolved in water (0.1 mg/mL); the second, third and fourth groups
were allowed to feed on water containing NDEA (0.1 mg/mL) plus
25, 50 and 100 mg/mL of Genistein, respectively; the ﬁfth group
served as a control (normal drinking water); the sixth, seventh and
eighth groups were allowed to feed on water containing Genistein at
ﬁnal concentration of 25, 50 and 100 mg/mL, respectively. The ninth
group was taken as a negative control, and was allowed to feed on
water containing a dimethysulfoxide (DMSO) (3 mL/mL). Genistein
was dissolved in 0.03% DMSO and in drinking water the ﬁnal
concentrations of 25, 50 and 100 mg/mL were established. The rats
were allowed to feed ad libitum for 21 days and were sacriﬁced under
mild ether anesthesia.2.3. Histological evaluation of the liver
A portion of the liver was removed and washed thoroughly with
0.9% saline. The tissue was kept in 10% buffered neutral formalin
(BNF) for 24 h. Then the ﬁxed liver specimens from each group
were embedded in parafﬁn and processed for light microscopy by
staining individual sections with hematoxylin–eosin stain.2.4. Biochemical analysis
The blood samples were collected directly by cardiac puncture in a
vacutainer having a clot activator (AKÜ ret, Medkit). The serum
samples were collected for the biochemical analysis of serum
glutamic oxaloacetic transaminase (SGOT), serum glutamic-
pyruvic transaminase (SGPT), alkaline phosphatase (ALP) and
lactate dehydrogenase (LDH). The levels of the enzymes wereestimated according to the method described in the commercial
kits (Crest Biosystem, India).
2.5. Preparation of liver homogenate
The homogenate was prepared according to the procedure
described by Singh et al. [23]. The livers were washed thoroughly
with chilled 0.9% saline. The ﬁnal wash was given with chilled
homogenizing buffer (pH 7.5) containing 0.024 M EDTA,
0.075 M NaCl and 10% DMSO. After weighing, the liver was
cut into pieces, suspended in chilled homogenizing buffer at a
concentration of 1 g/mL, and homogenized on ice using homo-
genizer at 1500 rpm. The homogenate was then centrifuged at
7000 rpm for 10 min at 4 1C. The supernatant was removed,
resuspended in a homogenization buffer and kept at 20 1C for
further analyses.
2.6. Estimation of protein carbonyl content
The protein carbonyl content was estimated according to the
protocol described by Hawkins [24] and Ali et al. [25].
2.7. Estimation of lipid peroxidation
The method described by Siddique et al. [26] was used for the
estimation of lipid peroxidation in liver cells. The absorbance was
read at 586 nm [25].
2.8. Micronucleus assay
Micronucleus assay was performed according to the method of
Igarashi and Shimada [27]. A total of 500 cells were counted per
rat for the presence of micronuclei using a light microscope
[25,27,28].
2.9. Comet assay
Comet assay was performed according to the method described by
Singh et al. [29]; and with modiﬁcation as suggested by Dhawan
et al. [30]. Frosted microscopic slides were dipped in 1% normal
melting agarose and the underside was wiped to remove the
agarose (dissolved in PBS). About 40 mL of the cell suspension
(liver cells) was mixed with 60 mL of 0.5% low melting agarose
(dissolved in PBS) and was layered on the prepared base slides.
Three slides were prepared per rat and a total of 50 randomly
captured comets per slide were analyzed under ﬂuorescence
microscope for scoring comet tail length by using comet 1.5
software (TriTek Corporation) [25].
2.10. Statistical analysis
All data were expressed as the mean7standard error and student’s
t-test was used for the analysis. Statistical signiﬁcance was
estimated at the 5% level.3. Results and discussion
The HE staining of histological sections of the liver showed the
normal structure of the hepatocytes in the control group (Fig. 1A).
The rats exposed to NDEA (0.1 mg/mL) showed sinusoidal
Fig. 2 Serum glutamic oxaloacetic transaminase (SGOT) activity
measured after 21 days of treatment of N-nitrosodiethylamine sepa-
rately and together with different doses of Genistein in rats.
[NDEA¼N-Nitrosodiethylamine; G1¼Genistein (25 mg/mL);
G2¼Genistein (50 mg/mL); G3¼Genistein (100 mg/mL); and nega-
tive control¼Dimethyl sulfoxide (3 mL/mL). a—Signiﬁcant with
respect to control. b—Signiﬁcant with respect to NDEA treatment.]
(Po0.05).
Fig. 3 Serum glutamic pyruvic transaminase (SGPT) activity mea-
sured after 21 days of treatment of N-nitrosodiethylamine separately
and together with different doses of Genistein in rats. [NDEA¼
N-Nitrosodiethylamine; G1¼Genistein (25 mg/mL); G2¼Genistein
(50 mg/mL); G3¼Genistein (100 mg/mL); and negative con-
trol¼Dimethyl sulfoxide (3 mL/mL). a—Signiﬁcant with respect to
control. b—Signiﬁcant with respect to NDEA treatment.] (Po0.05).
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deformities were reduced as the rats were exposed to different
doses of Genistein together with NDEA (0.1 mg/mL). Fig. 1C
shows the protective effect in rats exposed to 100 mg/mL of
Genistein together with 0.1 mg/mL of NDEA. The results obtained
for various enzymes activity in the blood serum are shown in
Figs. 2–5. The SGOT activity (U/mL) in the group of rats exposed
to NDEA (0.1 mg/mL) was associated with the mean value of
8071.531. The rats exposed to 25, 50 and 100 mg/mL of
Genistein together with NDEA (0.1 mg/mL) were associated with
the mean SGOT activity of 5071.032, 4171.210 and
3271.013 U/mL, respectively (Fig. 2). The control group was
associated with the mean SGOT of 2871.241 U/mL. The rats
exposed to 25, 50 and 100 mg/mL of Genistein were associated
with the mean SGOT values of 3071.043, 3171.041 and
2771.032 U/mL, respectively (Fig. 2). A signiﬁcant decrease in
the mean values of SGPT (U/mL) was observed in the rats
exposed to NDEA combined with 25 (4271.43), 50 (3971.31)
and 100 mg/mL (3171.62) of Genistein as compared to the rats
exposed to NDEA alone (5571.21) (Fig. 3). The group of rats
exposed to 25, 50 and 100 mg/mL of Genistein did not show a
signiﬁcant increase in the mean values for SGPT (U/mL) (Fig. 3).
A signiﬁcant decrease in the mean values of ALP (U/L) was
observed in the rats exposed to 0.1 mg/mL of NDEA combined
with 25 (32071.13), 50 (29071.02) and 100 (28171.24) mg/mL
of Genistein compared to the rats exposed to 0.1 mg/mL of NDEA
alone (Fig. 4). The rats exposed to 25, 50 and 100 mg/mL of
Genistein did not show any signiﬁcant increase in the mean values
of ALP (U/L) (Fig. 4). A signiﬁcant decrease in the mean values of
LDH (U/L) was observed in rats exposed to 25, 50 and 100 mg/mL
of Genistein together with 0.1 mg/mL of NDEA, compared to the
group of rats exposed to NDEA alone (Fig. 5). The results obtained
for lipid peroxidation assay are shown in Fig. 6. A signiﬁcant
decrease in the mean absorbance values for lipid peroxidation was
observed in the rats exposed to 25, 50 and 100 mg/mL of Genistein
together with 0.1 mg/mL of NDEA compared to the group of rats
exposed to 0.1 mg/mL of NDEA alone (Fig. 6). A signiﬁcant
decrease in the mean absorbance values for protein carbonyl content
was observed in the group of rats exposed to 25, 50 and 100 mg/mL
of Genistein together with 0.1 mg/mL of NDEA, as compared to the
group of rats exposed to NDEA (0.1 mg/mL) alone (Fig. 7). The
results obtained for micronucleus assay are shown in Fig. 8 (A and
B). A signiﬁcant decrease in the mean values of micronucleated
cells was observed in the rats exposed to 25 (0.016870.321), 50
(0.01470.121) and 100 (0.012470.321) mg/mL of Genistein
together with 0.1 mg/mL of NDEA as compared to the group of
rats exposed to 0.1 mg/mL NDEA alone (Fig. 8C). No signiﬁcant
increase in the mean values of micronucleated cells was observed in
rats exposed to 25, 50 and 100 mg/mL of Genistein (Fig. 8C), asFig. 1 Microscopic illustrations of the liver of rats stained by hematoxylin
exposed to 0.1 mg/mL of NDEA together with 100 mg/mL of Genistein.compared to the control group of rats (Fig. 8C). The results obtained
for the comet assay performed on hepatocytes are shown in Fig. 9(A
and B). A signiﬁcant decrease in the mean tail length was observed
in the group of rats exposed to 25 (6470.43), 50 (6170.67) and–eosin. (A) Control; (B) NDEA (0.1 mg/mL) for 21 days; and (C) rats
Fig. 4 Serum alkaline phosphatase (ALP) activity measured after 21
days of treatment of N-nitrosodiethylamine separately and together
with different doses of Genistein in rats. [NDEA¼N-Nitrosodiethy-
lamine; G1¼Genistein (25 mg/mL); G2¼Genistein (50 mg/mL);
G3¼Genistein (100 mg/mL); and negative control¼Dimethyl sulf-
oxide (3 mL/mL). a—Signiﬁcant with respect to control. b—Signiﬁ-
cant with respect to NDEA treatment.] (Po0.05).
Fig. 5 Lactate dehydrogenase (LDH) activity in serum after 21 days
of treatment of N-nitrosodiethylamine separately and together with
different doses of Genistein in rats. [NDEA¼N-Nitrosodiethylamine;
G1¼Genistein (25 mg/mL) ; G2¼Genistein (50 mg/mL) ; G3¼
Genistein (100 mg/mL); and negative control¼Dimethyl sulfoxide
(3 mL/mL). a—Signiﬁcant with respect to control. b—Signiﬁcant with
respect to NDEA treatment.] (Po0.05).
Fig. 6 Lipid peroxidation measured in rat liver after 21 days of
treatment of N-nitrosodiethylamine separately and together with
different doses of Genistein in rats. [NDEA¼N-Nitrosodiethylamine;
G1¼Genistein (25 mg/mL); G2¼Genistein (50 mg/mL); G3¼
Genistein (100 mg/mL); and negative control¼Dimethyl sulfoxide
(3 mL/mL). a—Signiﬁcant with respect to control. b—Signiﬁcant with
respect to NDEA treatment.] (Po0.05).
Fig. 7 Protein carbonyl content measured in rat liver after 21 days of
treatment of N-nitrosodiethylamine separately and together with different
doses of Genistein. [NDEA¼N-Nitrosodiethylamine; G1¼Genistein
(25 mg/mL); G2¼Genistein (50 mg/mL); G3¼Genistein (100 mg/mL);
and negative control¼Dimethyl sulfoxide (3 mL/mL). a—Signiﬁcant with
respect to control. b—Signiﬁcant with respect to NDEA treatment.]
(Po0.05).
Fig. 8 Hepatocytes show micronuclei: (A) control and (B) treated
with NDEA (0.1 mg/mL). (C) Micronucleated cells in the hepatocytes
after 21 days of treatment of N-nitrosodiethylamine separately and
together with different doses of Genistein in rats. [NDEA¼N-
Nitrosodiethylamine; G1¼Genistein (25 mg/mL); G2¼Genistein
(50 mg/mL); G3¼Genistein (100 mg/mL); and negative con-
trol¼Dimethyl sulfoxide (3 mL/mL). a—Signiﬁcant with respect to
control. b—Signiﬁcant with respect to NDEA treatment.] (Po0.05).
F. Ali et al.54100 (5470.53) mg/mL of Genistein together with 0.1 mg/mL of
NDEA, compared to the group of rats exposed to NDEA (0.1 mg/
mL) alone (Fig. 9C). No signiﬁcant increase in the mean tail length
was observed in the group of rats exposed to 25, 50 and 100 mg/mL
of Genistein (Fig. 9C).
The results of the present study suggest the protective role of
Genistein against NDEA-induced hepatotoxicity in rats. NDEA
has been suggested to cause oxidative stress by generating reactive
oxygen species [31]. NDEA is metabolized to its active ethyl
radical metabolite (CH3CH2
þ) by the cytochrome P-450 dependent
monooxygenase [32]. This results in an increase in the serum
indices of liver function (SGOT, SGPT, ALP and LDH) as well as
Protective effect of Genistein against N-nitrosodiethylamine (NDEA)-induced hepatotoxicity in Swiss albino rats 55DNA damage in the liver cells in the present study. The DNA
damage is evident by a signiﬁcant increase in the MN frequency
and DNA tail length group as compared to control. It also results
in the formation of various histopathological lessions. Phytochem-
icals provide essential health value to our diet and are emerging as
key nutraceuticals. The poorly understood mechanism of action of
the vast majority of phytochemicals has led to the regulation of
dietary supplements and the understanding of how nutraceuticals
provide health value [33]. In our present study, the supplementa-
tion of Genistein together with NDEA results in a signiﬁcant dose-
dependent decrease in the toxic effects induced by the treatment of
NDEA alone.
After ingestion Genistein is metabolized to dihydroGenistein
and 6-hydroxy-o-desmethylangolensin. However, it is still unclear
whether the active ingredient in vivo is the parent compound or a
metabolite [34]. The two features of ﬂavonoids have been
suggested for their biological functions i.e. their antioxidant
properties and their ability to act as signal molecules by interacting
with proteins [35]. Although isoﬂavones have been reported to be
antioxidants by scavenging free radicals [36,37], they also induceFig. 9 Comet assay performed in rat hepatocytes [(A) control and
(B) treated with NDEA (0.1 mg/mL)]. Comet assay in the hepatocytes
after 21 days of treatment of N-nitrosodiethylamine separately and
together with different doses of Genistein in rats (C). [NDEA¼
N-Nitrosodiethylamine; G1¼Genistein (25 mg/mL); G2¼Genistein
(50 mg/mL); G3¼Genistein (100 mg/mL); and negative con-
trol¼Dimethyl sulfoxide (3 mL/mL). a—Signiﬁcant with respect to
control. b—Signiﬁcant with respect to NDEA treatment] (Po0.05).
Fig. 10 Possible mechanism of the metabolic activation of N-nitrothe expression of antioxidant genes [7]. The administration of
Genistein to cancer patients showed the plasma concentration of
the parent compound corresponding to those achieved in anti-
neoplastic in vitro studies [38]. The exposure of rats to 0.1 mg/mL
of NDEA for 21 days showed liver damage as evidenced by the
increase in the level of aspartate aminotransferase (SGOT), alanine
aminotransferase (SGPT), ALP and LDH. Any damage to the liver
cells leads to the rise in the level of these enzymes in the blood
stream serving as a potential marker of the liver damage [39]. The
exposure of rats to NDEA combined with various doses of
Genistein showed a dose-dependent decrease in the levels of these
enzymes, thus conﬁrming a protective role of Genistein against
NDEA-induced liver damage. The metabolic activation of NDEA
leads to the formation of ethyl radical (CH3CH2
þ), causing the
damage of plasma membrane [32]. The resulting reactive oxygen
species may cause the oxidation of protein [32]. The rats exposed
to NDEA showed a signiﬁcant increase in the lipid peroxidation
and protein carbonyl content as compared to untreated ones. The
rats exposed to NDEA together with different doses of Genistein
showed a signiﬁcant dose-dependent decrease in the lipid perox-
idation and protein carbonyl content, thus conﬁrming the antiox-
idant role of Genistein in the treated rats. It may be due to the
scavenging of free radicals [36,37] or by enhancing expression of
antioxidant genes [7]. The selected doses of Genistein in our
present study successfully reduced the toxic effects of NDEA in
rats. However, some in vitro studies have demonstrated Genistein
as a clastogenic and also a mutagenic agent [40,41]. In a more
reﬁned study, Genistein was found to be negative for bacterial
mutations and genotoxicity in the in vivo micronucleus test even at
2000 mg/kg [15]. In Asian males and females, the plasma
concentrations of total Genistein are approximately 500 nM. The
study performed on rats for micronucleus assay showed 80% and
49% increase in the average peak plasma level for total Genistein
for male and female rats respectively, with no increase in the
micronuclei [15]. There is a wide margin of safety with respect to
Genistein intake in humans. The selected doses of Genistein in our
present study did not show any toxic effects on rats. Once
absorbed, a small fraction of the isoﬂavones circulates systemi-
cally in their unconjugated form [42]. The blood serum concentra-
tion of Genistein may vary among individuals due to differences in
metabolic handling of the isoﬂavones [42]. In in vitro study, the
pre-incubation of cultured cancerous prostate cells with Genistein
reduced H2O2-induced DNA damage [7]. Similar properties of
Genistein were reported in human lymphocytes [43,44]. Consider-
ing the results obtained in our study and other studies carried out
in vivo and in vitro, the possible mechanism for protection by
Genistein against NDEA is shown in Fig. 10. Patel et al. [36] have
shown that the polysaturated fatty acids reduce the phenoxylsodiethyl amine (NDEA) and the protective role of Genistein.
F. Ali et al.56radical formed as a result of reaction polyphenols with lipid
peroxyl radicals, thereby regenerating Genistein and peroxyl
radical, thus delaying the effect of peroxyl radical [6].4. Conclusion
The results of the present study reveal that Genistein reduces not
only the levels of blood serum enzymes but also the genotoxic
damage as well as oxidative stress induced by NDEA. Hence, it is
concluded that Genistein is potent in reducing the toxic effects of
NDEA in Swiss albino rats.Acknowledgments
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